All research
2026-06-30 PubMed

Mobile app significantly boosts insulin knowledge, self-management, and injection skills in Type 2 Diabetes patients

Effects of a Mobile Application for Patients With Type 2 Diabetes Initiating Insulin Therapy: Randomized Controlled Trial.

Background

Initiating insulin therapy for Type 2 Diabetes (T2D) can be a complex and daunting process for patients, often leading to anxiety, poor adherence, and suboptimal glycemic control. Traditional education methods, while valuable, may lack the continuity and personalized support needed to fully empower patients in managing their condition. There's a critical gap in accessible, engaging tools that can effectively enhance patient understanding, practical skills, and positive attitudes towards insulin use from the outset. Addressing this gap could significantly improve patient outcomes and reduce the burden on healthcare systems by fostering greater self-efficacy.

Study Design

This randomized controlled study involved 88 participants with Type 2 Diabetes initiating insulin therapy for the first time. Participants were assigned by block randomization to either an intervention group (n=44) or a control group (n=44). The intervention group received insulin training via a mobile application, while the control group received standard care. Data were collected at baseline (T1), on the 14th day (T2), and on the 28th day (T3) using several validated instruments, including the Insulin Knowledge Form, Insulin Treatment Assessment Scale, Insulin Treatment Self-Management Scale, and Insulin Injection Skill Observation Form to assess primary endpoints.

Results

In the intervention group utilizing the mobile application, a statistically significant increase over time was observed across multiple key metrics. Levels of insulin-related knowledge, self-management of insulin treatment, and insulin injection skills all showed significant improvements (p < 0.05). Concurrently, negative attitudes and perceptions regarding insulin treatment decreased significantly (p < 0.05) within this group. Conversely, the control group, which received standard care, exhibited no statistically significant changes in any of these parameters over the 28-day study period (p > 0.05).

Key Findings

  • Mobile app significantly increased insulin-related knowledge in patients (p < 0.05).
  • Mobile app improved self-management of insulin treatment (p < 0.05).
  • Mobile app enhanced insulin injection skills (p < 0.05).
  • Negative attitudes towards insulin treatment decreased with mobile app use (p < 0.05).

Why It Matters

This study highlights a practical and scalable solution for improving patient engagement and outcomes in Type 2 Diabetes when initiating insulin. Integrating a mobile application into routine diabetes education programs could standardize and enhance the quality of initial insulin training, potentially reducing patient anxiety and improving long-term adherence. For individuals, this means a more accessible and continuous learning resource, empowering them to confidently manage their insulin therapy. Clinically, this approach could free up nursing time, ensure consistent educational delivery, and foster positive behavioral changes that are crucial for effective disease self-management, ultimately leading to better glycemic control and fewer complications.


mobile app type 2 diabetes insulin therapy patient education self-management randomized controlled trial
Source: pubmed:42374657 · Ingested 2026-06-30 · Digest: gemini-2.5-flash